FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Roberto Marchioli

Research Profile

Concepts & Ideas

Chemicals & Drugs

Disorders

Geographic Areas

Italy

Anatomy

Thrombosis

Co-author Network

Publications

TOP 3
Fausto Avanzini; Simona Barlera; Vittorio Caimi; Paolo Longoni; Irene Marzona; Valentina Milani; Maria Carla Roncaglioni; Maria Giuseppina Silletta; Gianni Tognoni; Massimo Tombesi; Roberto Marchioli
n-3 fatty acids in patients with multiple cardiovascular risk factors.
Roberto Marchioli; Alessandro Maria Vannucchi; Tiziano Barbui
Treatment target in polycythemia vera.
Hans Konrad Biesalski; Kathleen Ellwood; John W Erdman; John Hathcock; Elizabeth Johnson; Lotte Lauritzen; Roberto Marchioli; Harry B Rice; Andrew Shao; Stephen Beatty; James C Griffiths
Nutrient reference values for bioactives: new approaches needed? A conference report.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Roberto Marchioli (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Fausto Avanzini; Simona Barlera; Vittorio Caimi; Paolo Longoni; Irene Marzona; Valentina Milani; Maria Carla Roncaglioni; Maria Giuseppina Silletta; Gianni Tognoni; Massimo Tombesi; Roberto Marchioli
n-3 fatty acids in patients with multiple cardiovascular risk factors.
The New England journal of medicine 2013;368(19):1800-8.
2013: Roberto Marchioli; Alessandro Maria Vannucchi; Tiziano Barbui
Treatment target in polycythemia vera.
The New England journal of medicine 2013;368(16):1556.
2013: Hans Konrad Biesalski; Kathleen Ellwood; John W Erdman; John Hathcock; Elizabeth Johnson; Lotte Lauritzen; Roberto Marchioli; Harry B Rice; Andrew Shao; Stephen Beatty; James C Griffiths
Nutrient reference values for bioactives: new approaches needed? A conference report.
European journal of nutrition 2013;52 Suppl 1():1-9.
2013: Giacomo Levantesi; AldoPietro Maggioni; Maria Grazia Franzosi; Rosa Maria Marfisi; Dariush Mozaffarian; Gian Luigi Nicolosi; Carlo Schweiger; Maria Giuseppina Silletta; Luigi Tavazzi; Gianni Tognoni; Roberto Marchioli
Wine consumption and risk of cardiovascular events after myocardial infarction: results from the GISSI-Prevenzione trial.
International journal of cardiology 2013;163(3):282-7.
2013: Dariush Mozaffarian; Roberto Marchioli
Fish oil vs olive oil for postoperative atrial fibrillation--reply.
JAMA : the journal of the American Medical Association 2013;309(9):871-2.
2013: Raffaele De Caterina; Roberto Marchioli; Felicita Andreotti
Bedside monitoring of antiplatelet therapy for coronary stenting.
The New England journal of medicine 2013;368(9):871.
2013: Serge Masson; Valentina Milani; Dariush Mozaffarian; Enrico Nicolis; Mariateresa Tacconi; Luigi Tavazzi; Gianni Tognoni; Roberto Bernasconi; Luisa Borgese; Vincenzo Cirrincione; Luana Dragani; Oreste Febo; Aldo P Maggioni; Roberto Marchioli; Rosa Maria Marfisi; Roberto Latini
Plasma n-3 polyunsaturated fatty acids in chronic heart failure in the GISSI-Heart Failure Trial: relation with fish intake, circulating biomarkers, and mortality.
American heart journal 2013;165(2):208-15.e4.
2013: Maria Teresa La Rovere; Roberto Latini; Roberto Maestri; Aldo P Maggioni; Roberto Marchioli; Alessandro Mezzani; Paolo Midi; Lidia Staszewsky; Luigi Tavazzi; Gianni Tognoni; Simona Barlera
n-3PUFA and Holter-derived autonomic variables in patients with heart failure: data from the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca (GISSI-HF) Holter substudy.
Heart rhythm : the official journal of the Heart Rhythm Society 2013;10(2):226-32.
2013: Simona Barlera; Maria Grazia Franzosi; Donata Lucci; Aldo P Maggioni; Roberto Marchioli; Serge Masson; Gian Luigi Nicolosi; Elena Raimondi; Luigi Tavazzi; Gianni Tognoni; Renato Urso
Predictors of mortality in 6975 patients with chronic heart failure in the Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico-Heart Failure trial: proposal for a nomogram.
Circulation. Heart failure 2013;6(1):31-9.
2012: Maria Teresa La Rovere; Roberto Maestri; Roberto Marchioli; Gian Luigi Nicolosi; Gian Domenico Pinna; Luigi Tavazzi; Marco Veniani; Simona Barlera; Marino Bernardinangeli
Autonomic markers and cardiovascular and arrhythmic events in heart failure patients: still a place in prognostication? Data from the GISSI-HF trial.
European journal of heart failure 2012;14(12):1410-9.
2012: Raffaele Landolfi; Leonardo Di Gennaro; Igor Giarretta; RosaMaria Marfisi; Maria Anna Nicolazzi; Roberto Marchioli
Polycythemia vera: gender-related phenotypic differences.
Internal and emergency medicine 2012;7(6):509-15.
2012: Roberto Marchioli; Giacomo Levantesi
Why Do We Still Need Large Scale Clinical Trial: The Case of n-3 PUFA.
Frontiers in physiology 2012;3():202.
2011: Marco Matteo Ciccone; Francesca Cortese; Giovanni de Pergola; Lucia Diaferio; Santa Carbonara; Michele Gesualdo; Paola Giordano; Roberto Marchioli; Giuseppe Mercuro; Vito Leonardo Miniello; Vincenzo Palumbo; Stefano Giuseppe Primitivo; Gabriella Ricci; Marco Sassara; Pietro Scicchitano; Stefano Favale
Morphological and functional vascular changes induced by childhood obesity.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2011;18(6):831-5.
2011: Maria Giuseppina Silletta; Antonio Pio D'Ingianna; Roberto Giugliano; Raffaella Pioggiarella; Michele Ruo; Marco Scarano; Roberto Marchioli
[Lyfestiles, health and cardiovascular risk: the results of the study "Rischio & Prevenzione"].
Assistenza infermieristica e ricerca : AIR 2011;30(4):198-207.
2011: Paola Guglielmelli; Maria Letizia Lupo; Elisa Malevolti; Roberto Marchioli; Arianna Masciulli; Ubaldo Occhini; Alessandro Pancrazzi; Simona Paratore; Lisa Pieri; Alessandro Rambaldi; Maria Chiara Susini; Lorenzo Tozzi; Emilio Usala; Alessandro M Vannucchi; Elisabetta Antonioli; Tiziano Barbui; Giovanni Barosi; Niccolò Bartalucci; Flavia Biamonte; Alberto Bosi; Silvia Caglio; Guido Finazzi; Elisabetta Gattoni; Alberto Grossi
Safety and efficacy of everolimus, a mTOR inhibitor, as single agent in a phase 1/2 study in patients with myelofibrosis.
Blood 2011;118(8):2069-76.
2011: Bruno Trimarco; Luigi Tavazzi; Roberto Marchioli
[The Alpha Omega study].
Giornale italiano di cardiologia (2006) 2011;12(7-8):469-73.
2011: Dariush Mozaffarian; Patrick O'Gara; Richard Page; Massimo Santini; Luigi Tavazzi; Paolo Ferrazzi; Tim Gardner; Roberto Latini; Peter Libby; Federico Lombardi; Alejandro Macchia; Roberto Marchioli; Gianni Tognoni
The ω-3 Fatty Acids for Prevention of Post-Operative Atrial Fibrillation trial--rationale and design.
American heart journal 2011;162(1):56-63.e3.
2011: Andrea A Finzi; Roberto Latini; Simona Barlera; Maria G Rossi; Albarosa Ruggeri; Alessandro Mezzani; Chiara Favero; Maria G Franzosi; Domenico Serra; Donata Lucci; Francesca Bianchini; Roberto Bernasconi; Aldo P Maggioni; Gianluigi Nicolosi; Maurizio Porcu; Gianni Tognoni; Luigi Tavazzi; Roberto Marchioli
Effects of n-3 polyunsaturated fatty acids on malignant ventricular arrhythmias in patients with chronic heart failure and implantable cardioverter-defibrillators: A substudy of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca (GISSI-HF) trial.
American heart journal 2011;161(2):338-343.e1.
2011: Tiziano Barbui; Alessandra Carobbio; Guido Finazzi; Alessandro M Vannucchi; Giovanni Barosi; Elisabetta Antonioli; Paola Guglielmelli; Alessandro Pancrazzi; Silvia Salmoiraghi; Pio Zilio; Cosimo Ottomano; Roberto Marchioli; Ivan Cuccovillo; Barbara Bottazzi; Alberto Mantovani; Alessandro Rambaldi
Inflammation and thrombosis in essential thrombocythemia and polycythemia vera: different role of C-reactive protein and pentraxin 3.
Haematologica 2011;96(2):315-8.
2011: Roberto Marchioli; Arianna Masciulli; Maria Rosaria Mennitto; Giorgina Specchia; Guido Finazzi; Tiziano Barbui
The CYTO-PV: A Large-Scale Trial Testing the Intensity of CYTOreductive Therapy to Prevent Cardiovascular Events in Patients with Polycythemia Vera.
Thrombosis 2011;2011():794240.
2011: Maurizio Galderisi; Pasquale Innelli; Maria-Angela Losi; Roberto Marchioli; Paolo Nicola Marino; Giuliano Marti; Donato Mele; Giuseppe Mercuro; Sergio Mondillo; Denisa Muraru; Stefano Nistri; Alessandro Santoro; Aurelio Sgalambro; Eustachio Agricola; Luigi P Badano; Piercarlo Ballo; Antonello D'Andrea; Roberta Esposito; Pasquale Perrone Filardi
Methodological approach for the assessment of ultrasound reproducibility of cardiac structure and function: a proposal of the study group of Echocardiography of the Italian Society of Cardiology (Ultra Cardia SIC) part I.
Cardiovascular ultrasound 2011;9():26.
2010: Stefano Ghio; Laura Scelsi; Roberto Latini; Serge Masson; Ermanno Eleuteri; Michela Palvarini; Olga Vriz; Michele Pasotti; Marco Gorini; Roberto Marchioli; Aldo Maggioni; Luigi Tavazzi
Effects of n-3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI-HF trial.
European journal of heart failure 2010;12(12):1345-53.
2010: Giovanni Barosi; Elisabetta Gattoni; Paola Guglielmelli; Rita Campanelli; Fabio Facchetti; Simona Fisogni; Judith Goldberg; Roberto Marchioli; Ronald Hoffman; Alessandro M Vannucchi
Phase I/II study of single-agent bortezomib for the treatment of patients with myelofibrosis. Clinical and biological effects of proteasome inhibition.
American journal of hematology 2010;85(8):616-9.
2010: Serge Masson; Roberto Latini; Emanuele Carbonieri; Luciano Moretti; Maria Grazia Rossi; Santo Ciricugno; Valentina Milani; Roberto Marchioli; Joachim Struck; Andreas Bergmann; Aldo P Maggioni; Gianni Tognoni; Luigi Tavazzi
The predictive value of stable precursor fragments of vasoactive peptides in patients with chronic heart failure: data from the GISSI-heart failure (GISSI-HF) trial.
European journal of heart failure 2010;12(4):338-47.
2010: Alejandro Macchia; Roberto Marchioli; Gianni Tognoni; Marco Scarano; Rosa Maria Marfisi; Luigi Tavazzi; Stuart Rich
Systematic review of trials using vasodilators in pulmonary arterial hypertension: why a new approach is needed.
American heart journal 2010;159(2):245-57.
2010: Raffaele De Caterina; Marco Scarano; Rosamaria Marfisi; Giuseppe Lucisano; Francesco Palma; Alfonso Tatasciore; Roberto Marchioli
Cholesterol-lowering interventions and stroke: insights from a meta-analysis of randomized controlled trials.
Journal of the American College of Cardiology 2010;55(3):198-211.
2010: Giacomo Levantesi; Maria Giuseppina Silletta; Roberto Marchioli
Uses and benefits of omega-3 ethyl esters in patients with cardiovascular disease.
Journal of multidisciplinary healthcare 2010;3():79-96.
2010: Miriam Valentini; Maria Celeste Pirozzoli; Daniela D'Alonzo; Luisella Pirozzi; Caterina Anecchino; Francesca Tuzi; Marilena Romero; Antonio Nicolucci; Giovanni F M Strippoli; Maurizio Belfiglio; Roberto Marchioli; Arianna Masciulli; Maria G Silletta; Gianni Tognoni
[Memorandum for the management of clinical trials].
Assistenza infermieristica e ricerca : AIR 2010;29(1):26-40.
2010: Roberto Marchioli; Maria Giuseppina Silletta; Giacomo Levantesi; R Pioggiarella; G Tognoni
N-3 polyunsaturated fatty acids in heart failure: mechanisms and recent clinical evidence.
Cellular and molecular biology (Noisy-le-Grand, France) 2010;56(1):110-30.
2010: Serge Masson; Roberto Latini; Valentina Milani; Luciano Moretti; Maria Grazia Rossi; Emanuele Carbonieri; Anna Frisinghelli; Calogero Minneci; Massimiliano Valisi; Aldo P Maggioni; Roberto Marchioli; Gianni Tognoni; Luigi Tavazzi
Prevalence and prognostic value of elevated urinary albumin excretion in patients with chronic heart failure: data from the GISSI-Heart Failure trial.
Circulation. Heart failure 2010;3(1):65-72.
2009: Roberto Marchioli; Maria Giuseppina Silletta; Giacomo Levantesi; Raffaella Pioggiarella
Omega-3 fatty acids and heart failure.
Current atherosclerosis reports 2009;11(6):440-7.
2009: Aldo P Maggioni; Gianna Fabbri; Donata Lucci; Roberto Marchioli; Maria Grazia Franzosi; Roberto Latini; Gian Luigi Nicolosi; Maurizio Porcu; Franco Cosmi; Severo Stefanelli; Gianni Tognoni; Luigi Tavazzi
Effects of rosuvastatin on atrial fibrillation occurrence: ancillary results of the GISSI-HF trial.
European heart journal 2009;30(19):2327-36.
2009: Roberto Marchioli; Giacomo Levantesi; Maria G Silletta; Simona Barlera; Marino Bernardinangeli; Emanuele Carbonieri; Francesco Cosmi; Maria Grazia Franzosi; Roberto Latini; Donata Lucci; Aldo Pietro Maggioni; Luciano Moretti; Gian L Nicolosi; Maurizio Porcu; Maria G Rossi; Gianni Tognoni; Luigi Tavazzi
Effect of n-3 polyunsaturated fatty acids and rosuvastatin in patients with heart failure: results of the GISSI-HF trial.
Expert review of cardiovascular therapy 2009;7(7):735-48.
2008: Pantaleo Giannuzzi; Pier Luigi Temporelli; Roberto Marchioli; Aldo Pietro Maggioni; Gianluigi Balestroni; Vincenzo Ceci; Carmine Chieffo; Marinella Gattone; Raffaele Griffo; Carlo Schweiger; Luigi Tavazzi; Stefano Urbinati; Franco Valagussa; Diego Vanuzzo
Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network.
Archives of internal medicine 2008;168(20):2194-204.
2008: Maria Giuseppina Silletta; Roberto Marchioli
[Coffee and cardiovascular disease risk: yin and yang].
Recenti progressi in medicina 2008;99(11):533-7.
2008: John H Lee; James H O'Keefe; Carl J Lavie; Roberto Marchioli; William S Harris
Omega-3 fatty acids for cardioprotection.
Mayo Clinic proceedings. Mayo Clinic 2008;83(3):324-32.
2008: Valerio De Stefano; Tommaso Za; Elena Rossi; Alessandro M Vannucchi; Marco Ruggeri; Elena Elli; Caterina Micò; Alessia Tieghi; Rossella R Cacciola; Cristina Santoro; Giancarla Gerli; Nicola Vianelli; Paola Guglielmelli; Lisa Pieri; Francesca Scognamiglio; Francesco Rodeghiero; Enrico Pogliani; Guido Finazzi; Luigi Gugliotta; Roberto Marchioli; Giuseppe Leone; Tiziano Barbui
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
Haematologica 2008;93(3):372-80.
2007: Maria Giuseppina Silletta; Rosa Maria Marfisi; Giacomo Levantesi; Alessandro Boccanelli; Carmine Chieffo; Maria Grazia Franzosi; Enrico Geraci; Aldo P Maggioni; Gian Luigi Nicolosi; Carlo Schweiger; Luigi Tavazzi; Gianni Tognoni; Roberto Marchioli
Coffee consumption and risk of cardiovascular events after acute myocardial infarction: results from the GISSI (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico)-Prevenzione trial.
Circulation 2007;116(25):2944-51.
2007: Giacomo Levantesi; Marco Scarano; Rosa Maria Marfisi; Giovanna Borrelli; Anne W S Rutjes; Maria Giuseppina Silletta; Gianni Tognoni; Roberto Marchioli
Meta-analysis of effect of statin treatment on risk of sudden death.
The American journal of cardiology 2007;100(11):1644-50.
2007: Roberto Marchioli; Rosa Maria Marfisi; Giovanna Borrelli; Carmine Chieffo; Maria Grazia Franzosi; Giacomo Levantesi; Aldo P Maggioni; Gian Luigi Nicolosi; Marco Scarano; Maria Giuseppina Silletta; Carlo Schweiger; Luigi Tavazzi; Gianni Tognoni
Efficacy of n-3 polyunsaturated fatty acids according to clinical characteristics of patients with recent myocardial infarction: insights from the GISSI-Prevenzione trial.
Journal of cardiovascular medicine (Hagerstown, Md.) 2007;8 Suppl 1():S34-7.
2007: Dariush Mozaffarian; Rosa Maria Marfisi; Giacomo Levantesi; Maria G Silletta; Luigi Tavazzi; Gianni Tognoni; Franco Valagussa; Roberto Marchioli
Incidence of new-onset diabetes and impaired fasting glucose in patients with recent myocardial infarction and the effect of clinical and lifestyle risk factors.
Lancet 2007;370(9588):667-75.
2007: Monica Galli; Giovanna Borrelli; Eva Marie Jacobsen; Rosa Maria Marfisi; Guido Finazzi; Roberto Marchioli; Finn Wisloff; Stefana Marziali; Olivier Morboeuf; Tiziano Barbui
Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study.
Blood 2007;110(4):1178-83.
2007: Benedetta D Chiodini; Maria Grazia Franzosi; Simona Barlera; STEFANO SIGNORINI; Cathryn M Lewis; Andria D'Orazio; Paolo Mocarelli; Enrico Nicolis; Roberto Marchioli; Gianni Tognoni
Apolipoprotein E polymorphisms influence effect of pravastatin on survival after myocardial infarction in a Mediterranean population: the GISSI-Prevenzione study.
European heart journal 2007;28(16):1977-83.
2007: Alessandro M Vannucchi; Elisabetta Antonioli; Paola Guglielmelli; Alessandro Rambaldi; Giovanni Barosi; Roberto Marchioli; Rosa Maria Marfisi; Guido Finazzi; Vittoria Guerini; Fabrizio Fabris; Maria Luigia Randi; Valerio De Stefano; Sabrina Caberlon; Agostino Tafuri; Marco Ruggeri; Giorgina Specchia; Vincenzo Liso; Edoardo Rossi; Enrico Pogliani; Luigi Gugliotta; Alberto Bosi; Tiziano Barbui
Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia.
Blood 2007;110(3):840-6.
2007: Alejandro Macchia; Roberto Marchioli; Rosa Maria Marfisi; Marco Scarano; Giacomo Levantesi; Luigi Tavazzi; Gianni Tognoni
A meta-analysis of trials of pulmonary hypertension: a clinical condition looking for drugs and research methodology.
American heart journal 2007;153(6):1037-47.
2007: Alessandra Carobbio; Guido Finazzi; Vittoria Guerini; Orietta Spinelli; Federica Delaini; Roberto Marchioli; Giovanna Borrelli; Alessandro Rambaldi; Tiziano Barbui
Leukocytosis is a risk factor for thrombosis in essential thrombocythemia: interaction with treatment, standard risk factors, and Jak2 mutation status.
Blood 2007;109(6):2310-3.
2007: Raffaele Landolfi; Leonardo Di Gennaro; Tiziano Barbui; Valerio De Stefano; Guido Finazzi; Rosa Maria Marfisi; Gianni Tognoni; Roberto Marchioli
Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera.
Blood 2007;109(6):2446-52.
2007: Marcello Di Nisio; Tiziano Barbui; Leonardo Di Gennaro; Giovanna Borrelli; Guido Finazzi; Raffaele Landolfi; Giuseppe Leone; Rosa Maria Marfisi; Ettore Porreca; Marco Ruggeri; Anne W S Rutjes; Gianni Tognoni; Alessandro M Vannucchi; Roberto Marchioli
The haematocrit and platelet target in polycythemia vera.
British journal of haematology 2007;136(2):249-59.
2006: Fausto Avanzini; Claudio Alli; Alessandro Boccanelli; Carmine Chieffo; Maria Grazia Franzosi; Enrico Geraci; Aldo P Maggioni; Rosa Maria Marfisi; Gian Luigi Nicolosi; Carlo Schweiger; Luigi Tavazzi; Gianni Tognoni; Franco Valagussa; Roberto Marchioli
High pulse pressure and low mean arterial pressure: two predictors of death after a myocardial infarction.
Journal of hypertension 2006;24(12):2377-85.
2006: Roberto Marchioli; Giacomo Levantesi; Alejandro Macchia; Rosa Maria Marfisi; Gian Luigi Nicolosi; Luigi Tavazzi; Gianni Tognoni; Franco Valagussa
Vitamin E increases the risk of developing heart failure after myocardial infarction: Results from the GISSI-Prevenzione trial.
Journal of cardiovascular medicine (Hagerstown, Md.) 2006;7(5):347-50.
2006: Alejandro Macchia; Giacomo Levantesi; Giovanna Borrelli; Maria Grazia Franzosi; Aldo P Maggioni; Rosa Maria Marfisi; Marco Scarano; Luigi Tavazzi; Gianni Tognoni; Franco Valagussa; Roberto Marchioli
A clinically practicable diagnostic score for metabolic syndrome improves its predictivity of diabetes mellitus: the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI)-Prevenzione scoring.
American heart journal 2006;151(3):754.e7-754.e17.
2006: Daria Roccatagliata; Fausto Avanzini; Lara Monesi; Vittorio Caimi; Davide Lauri; Paolo Longoni; Roberto Marchioli; Massimo Tombesi; Gianni Tognoni; Maria Carla Roncaglioni
Is global cardiovascular risk considered in current practice? Treatment and control of hypertension, hyperlipidemia, and diabetes according to patients' risk level.
Vascular health and risk management 2006;2(4):507-14.
2006: Federica Barzi; Mark Woodward; Rosa Maria Marfisi; Gianni Tognoni; Roberto Marchioli
Analysis of the benefits of a Mediterranean diet in the GISSI-Prevenzione study: a case study in imputation of missing values from repeated measurements.
European journal of epidemiology 2006;21(1):15-24.
2005: Pantaleo Giannuzzi; Pier Luigi Temporelli; Aldo P Maggioni; Vincenzo Ceci; Carmine Chieffo; Marinella Gattone; Raffaele Griffo; Roberto Marchioli; Carlo Schweiger; Luigi Tavazzi; Stefano Urbinati; Franco Valagussa
GlObal Secondary Prevention strategiEs to Limit event recurrence after myocardial infarction: the GOSPEL study. A trial from the Italian Cardiac Rehabilitation Network: rationale and design.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2005;12(6):555-61.
2005: Alejandro Macchia; Giacomo Levantesi; Rosa Maria Marfisi; Maria Grazia Franzosi; Aldo P Maggioni; Gian Luigi Nicolosi; Carlo Schweiger; Luigi Tavazzi; Gianni Tognoni; Franco Valagussa; Roberto Marchioli
[Determinants of late-onset heart failure in myocardial infarction survivors: GISSI Prevenzione trial results].
Revista española de cardiología 2005;58(11):1266-72.
2005: Roberto Marchioli; Guido Finazzi; Rosa Maria Marfisi; Gianni Tognoni; Tiziano Barbui
Clinical trials in myeloproliferative disorders: looking forward.
Seminars in hematology 2005;42(4):259-65.
2005: Alejandro Macchia; Giacomo Levantesi; Maria Grazia Franzosi; Enrico Geraci; Aldo P Maggioni; Rosa Maria Marfisi; Gian Luigi Nicolosi; Carlo Schweiger; Luigi Tavazzi; Gianni Tognoni; Franco Valagussa; Roberto Marchioli
Left ventricular systolic dysfunction, total mortality, and sudden death in patients with myocardial infarction treated with n-3 polyunsaturated fatty acids.
European journal of heart failure 2005;7(5):904-9.
2005: Giacomo Levantesi; Alejandro Macchia; Rosa Maria Marfisi; Maria Grazia Franzosi; Aldo P Maggioni; Gian Luigi Nicolosi; Carlo Schweiger; Luigi Tavazzi; Gianni Tognoni; Franco Valagussa; Roberto Marchioli
Metabolic syndrome and risk of cardiovascular events after myocardial infarction.
Journal of the American College of Cardiology 2005;46(2):277-83.
2005: Roberto Marchioli; Giacomo Levantesi; Alejandro Macchia; Aldo P Maggioni; Rosa Maria Marfisi; Maria Giuseppina Silletta; Luigi Tavazzi; Gianni Tognoni; Franco Valagussa
Antiarrhythmic mechanisms of n-3 PUFA and the results of the GISSI-Prevenzione trial.
The Journal of membrane biology 2005;206(2):117-28.
2005: Philipp L Goerttler; Edith März; Peter L Johansson; Björn Andreasson; Jack Kutti; Alison R Moliterno; Roberto Marchioli; Jerry L Spivak; Heike L Pahl
Thrombotic and bleeding complications in four subpopulations of patients with essential thrombocythemia defined by c-Mpl protein expression and PRV-1 mRNA levels.
Haematologica 2005;90(6):851-3.
2005: Guido Finazzi; Roberto Marchioli; V Brancaccio; P Schinco; Finn Wisloff; J Musial; F Baudo; M Berrettini; S Testa; A D'Angelo; G Tognoni; Tiziano Barbui
A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS).
Journal of thrombosis and haemostasis : JTH 2005;3(5):848-53.
2005: Roberto Marchioli; Guido Finazzi; Raffaele Landolfi; Jack Kutti; Heinz Gisslinger; Carlo Patrono; Raphael Marilus; Ana Villegas; Gianni Tognoni; Tiziano Barbui
Vascular and neoplastic risk in a large cohort of patients with polycythemia vera.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(10):2224-32.
2005: Guido Finazzi; Vanesa Caruso; Roberto Marchioli; Giovanni Capnist; Teodoro Chisesi; Carlo Finelli; Luigi Gugliotta; Raffaele Landolfi; Jack Kutti; Heinz Gisslinger; Raphael Marilus; Carlo Patrono; Enrico Pogliani; Maria Luigia Randi; Ana Villegas; Gianni Tognoni; Tiziano Barbui
Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational study.
Blood 2005;105(7):2664-70.
2004: Roberto Marchioli
[Chart of the post myocardial infarction risk: results of GISSI-Prevention].
Italian heart journal : official journal of the Italian Federation of Cardiology 2004;5 Suppl 8():86S-90S; discussion 115S-121S.
2004: Luigi Tavazzi; Gianni Tognoni; Maria Grazia Franzosi; Roberto Latini; Aldo P Maggioni; Roberto Marchioli; Gian Luigi Nicolosi; Maurizio Porcu
Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure.
European journal of heart failure 2004;6(5):635-41.
2004: Delia Di Stasi; Roberto Bernasconi; Roberto Marchioli; Rosa Maria Marfisi; Giovanna Rossi; Gianni Tognoni; Maria Teresa Tacconi
Early modifications of fatty acid composition in plasma phospholipids, platelets and mononucleates of healthy volunteers after low doses of n-3 polyunsaturated fatty acids.
European journal of clinical pharmacology 2004;60(3):183-90.
2004: Raffaele Landolfi; Roberto Marchioli; Jack Kutti; Heinz Gisslinger; Gianni Tognoni; Carlo Patrono; Tiziano Barbui
Efficacy and safety of low-dose aspirin in polycythemia vera.
The New England journal of medicine 2004;350(2):114-24.
2003: Federica Barzi; Mark Woodward; Rosa Maria Marfisi; Luigi Tavazzi; Franco Valagussa; Roberto Marchioli
Mediterranean diet and all-causes mortality after myocardial infarction: results from the GISSI-Prevenzione trial.
European journal of clinical nutrition 2003;57(4):604-11.
2003: Jerry L Spivak; Giovanni Barosi; Gianni Tognoni; Tiziano Barbui; Guido Finazzi; Roberto Marchioli; Monia Marchetti
Chronic myeloproliferative disorders.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2003;():200-24.
2002: Roberto Marchioli; Federica Barzi; Elena Bomba; Carmine Chieffo; Domenico Di Gregorio; Rocco Di Mascio; Maria Grazia Franzosi; Enrico Geraci; Giacomo Levantesi; Aldo P Maggioni; Loredana Mantini; Rosa Maria Marfisi; G Mastrogiuseppe; Nicola Mininni; Gian Luigi Nicolosi; Massimo Santini; Carlo Schweiger; Luigi Tavazzi; Gianni Tognoni; Corrado Tucci; Franco Valagussa
Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione.
Circulation 2002;105(16):1897-903.
2002: Cristofaro Raimondo De; Bianca Rocca; Roberto Marchioli; Raffaele Landolfi
Plasma protein oxidation is associated with an increase of procoagulant markers causing an imbalance between pro- and anticoagulant pathways in healthy subjects.
Thrombosis and haemostasis 2002;87(1):58-67.
2001: Roberto Marchioli; Fausto Avanzini; Federica Barzi; Carmine Chieffo; Augusto Di Castelnuovo; Maria Grazia Franzosi; Enrico Geraci; Aldo P Maggioni; Rosa Maria Marfisi; Nicola Mininni; Gian Luigi Nicolosi; M Santini; Carlo Schweiger; Luigi Tavazzi; Gianni Tognoni; Franco Valagussa
Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations: GISSI-Prevenzione mortality risk chart.
European heart journal 2001;22(22):2085-103.
2001: Roberto Marchioli
Vitamin E and cardiovascular disease.
Thrombosis and haemostasis 2001;85(5):758-60.
2001: Roberto Marchioli; Carlo Schweiger; Giacomo Levantesi; Luigi Tavazzi; Franco Valagussa
Antioxidant vitamins and prevention of cardiovascular disease: epidemiological and clinical trial data.
Lipids 2001;36 Suppl():S53-63.
2001: Roberto Marchioli; Carlo Schweiger; Luigi Tavazzi; Franco Valagussa
Efficacy of n-3 polyunsaturated fatty acids after myocardial infarction: results of GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico.
Lipids 2001;36 Suppl():S119-26.
2001: Maria Grazia Franzosi; massimo brunetti; Roberto Marchioli; Rosa Maria Marfisi; Gianni Tognoni; Franco Valagussa
Cost-effectiveness analysis of n-3 polyunsaturated fatty acids (PUFA) after myocardial infarction: results from Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-Prevenzione Trial.
PharmacoEconomics 2001;19(4):411-20.
2000: Roberto Marchioli; Franco Valagussa
The results of the GISSI-Prevenzione trial in the general framework of secondary prevention.
European heart journal 2000;21(12):949-52.
2000: R Di Mascio; Roberto Marchioli; G Tognoni
Cholesterol reduction and stroke occurrence: an overview of randomized clinical trials.
Cerebrovascular diseases (Basel, Switzerland) 2000;10(2):85-92.
1999: Roberto Marchioli
Antioxidant vitamins and prevention of cardiovascular disease: laboratory, epidemiological and clinical trial data.
Pharmacological research : the official journal of the Italian Pharmacological Society 1999;40(3):227-38.
1999: Monica Galli; Guido Finazzi; F Norbis; Stefana Marziali; Roberto Marchioli; Tiziano Barbui
The risk of thrombosis in patients with lupus anticoagulants is predicted by their specific coagulation profile.
Thrombosis and haemostasis 1999;81(5):695-700.
1999: JJ Michiels; Jack Kutti; P Stark; M Bazzan; Luigi Gugliotta; Roberto Marchioli; Martin Griesshammer; Perry van Genderen; Josette Brière; Jean-Jacques Kiladjian; Tiziano Barbui; Guido Finazzi; N I Berlin; T C Pearson; A C Green; S M Fruchtmann; Richard T Silver; E Hansmann; A Wehmeier; Eva Lengfelder; Raffaele Landolfi; Hans Michael Kvasnicka; Hans Carl Hasselbalch; Francisco Cervantes; J Thiele
Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis.
The Netherlands journal of medicine 1999;54(2):46-62.
1998: Licia Iacoviello; Francesco Burzotta; Augusto Di Castelnuovo; Francesco Zito; Roberto Marchioli; Maria Benedetta Donati
The 4G/5G polymorphism of PAI-1 promoter gene and the risk of myocardial infarction: a meta-analysis.
Thrombosis and haemostasis 1998;80(6):1029-30.
1998: Fausto Avanzini; Roberto Marchioli; Claudio Alli; Gianni Tognoni
Hypertension Optimal Treatment (HOT) trial.
Lancet 1998;352(9127):571-2; author reply 574-5.
1997: Sergio Cortelazzo; Andrea Rossi; Piera Viero; Piermario Bellavita; Roberto Marchioli; Rosa Maria Marfisi; Alessandro Rambaldi; Tiziano Barbui
BEAM chemotherapy and autologous haemopoietic progenitor cell transplantation as front-line therapy for high-risk patients with diffuse large cell lymphoma.
British journal of haematology 1997;99(2):379-85.
1997: Roberto Marchioli; A di Pasquale; Rosa Maria Marfisi; G Tognoni
Chronic infections and coronary heart disease. The GISSI-Prevenzione Investigators.
Lancet 1997;350(9083):1028-9; author reply 1029.
1997: Raffaele Landolfi; Roberto Marchioli; C Patrono
Mechanisms of bleeding and thrombosis in myeloproliferative disorders.
Thrombosis and haemostasis 1997;78(1):617-21.
1997: Andrea Rossi; Sergio Cortelazzo; Piermario Bellavita; Piera Viero; Renato Bassan; B Comotti; Roberto Marchioli; Rosa Maria Marfisi; Alessandro Rambaldi; Tiziano Barbui
Long-term haematological reconstitution following BEAM and autologous transplantation of circulating progenitor cells in non-Hodgkin's lymphoma.
British journal of haematology 1997;96(3):620-6.
1997: Raffaele Landolfi; Roberto Marchioli
European Collaboration on Low-dose Aspirin in Polycythemia Vera (ECLAP): a randomized trial.
Seminars in thrombosis and hemostasis 1997;23(5):473-8.
1996: R Di Mascio; Roberto Marchioli; F Vitullo; G Tognoni
[Hospital management of the acute cerebrovascular patient. Results of a study carried out in the region of Abruzzo].
Recenti progressi in medicina 1996;87(11):523-9.
1996: Roberto Marchioli; Raffaele Landolfi; T Barbui; G Tognoni
Feasibility of randomised clinical trials in rare diseases: the case of polycythemia vera.
Leukemia & lymphoma 1996;22 Suppl 1():121-7.
1996: Roberto Marchioli; R Di Mascio; Rosa Maria Marfisi; F Vitullo; Gianni Tognoni
Coffee intake and death from coronary heart disease. Coffee may have both short and long term effects.
BMJ (Clinical research ed.) 1996;312(7045):1539.
1996: Roberto Marchioli; Rosa Maria Marfisi; F Carinci; Gianni Tognoni
Meta-analysis, clinical trials, and transferability of research results into practice. The case of cholesterol-lowering interventions in the secondary prevention of coronary heart disease.
Archives of internal medicine 1996;156(11):1158-72.
1996: F Vitullo; Roberto Marchioli; R Di Mascio; L Cavasinni; A D Pasquale; G Tognoni
Family history and socioeconomic factors as predictors of myocardial infarction, unstable angina and stroke in an Italian population. PROGETTO 3A Investigators.
European journal of epidemiology 1996;12(2):177-85.
1996: Roberto Marchioli; E Bomba; G Tognoni
Sheffield risk and treatment table for cholesterol lowering in prevention of coronary heart disease. GISSI-Prevenzione Investigators.
Lancet 1996;347(8999):467-8; author reply 468-9.
1996: Tiziano Barbui; Sergio Cortelazzo; Andrea Rossi; Piera Viero; Piermario Bellavita; Maurizio Buelli; D Fracassetti; Renato Bassan; B Comotti; Roberto Marchioli; Rosa Maria Marfisi; Alessandro Rambaldi
Factors for rapid and sustained hematopoietic reconstitution by circulating progenitor-cell transplantation in non-Hodgkin's lymphoma.
Cancer chemotherapy and pharmacology 1996;38 Suppl():S110-4.
1996: R Di Mascio; Roberto Marchioli; F Vitullo; Gianni Tognoni
A positive relation between high hemoglobin values and the risk of ischemic stroke. Progetto 3A Investigators.
European neurology 1996;36(2):85-8.
1995: R Di Mascio; Roberto Marchioli; F Vitullo; A Di Pasquale; L Cavasinni; Gianni Tognoni
Serum cholesterol and risk of ischemic stroke: results of a case-control study. On behalf of PROGETTO 3A Investigators.
Preventive medicine 1995;24(2):128-33.
1994: Roberto Marchioli; J C Prieto; Gianni Tognoni
Surrogate end-points: the case of trials on coronary atherosclerotic plaque regression.
Clinical trials and meta-analysis 1994;29(2-3):139-76.
1994: R Di Mascio; Roberto Marchioli; Gianni Tognoni
From pharmacological promises to controlled clinical trials to meta-analysis and back: the case of nimodipine in cerebrovascular disorders.
Clinical trials and meta-analysis 1994;29(1):57-79.
1993: Roberto Marchioli; A Di Pasquale
[The biochemical, pharmacological and epidemiological reference picture of the GISSI-Prevention. The Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico].
Giornale italiano di cardiologia 1993;23(9):933-64.
1992: Claudio Alli; Fausto Avanzini; G Bettelli; F Colombo; R Corso; M Di Tullio; Roberto Marchioli; G Mariotti; M Radice; E Taioli
Prevalence and variability of orthostatic hypotension in the elderly. Results of the 'Italian study on blood pressure in the elderly (SPAA)'. The 'Gruppo di Studio Sulla Pressione Arteriosa nell'Anziano'.
European heart journal 1992;13(2):178-82.
1991: Gianni Tognoni; Claudio Alli; Fausto Avanzini; G Bettelli; F Colombo; R Corso; Roberto Marchioli; A Zussino
Randomised clinical trials in general practice: lessons from a failure.
BMJ (Clinical research ed.) 1991;303(6808):969-71.
1991: F Vitullo; R Di Mascio; A Di Pasquale; L Sciulli; Roberto Marchioli
[Can the changes in dietary fat intake reduce the risk of onset and development of atherosclerosis and of ischemic cardiopathy in particular?].
Giornale italiano di cardiologia 1991;21(4):361-74.
1989: F Avanzini; Claudio Alli; G Bettelli; M Di Tullio; Roberto Marchioli; G Tognoni
[Isolated systolic hypertension in the elderly].
Medicina (Florence, Italy) 1989;9(4):380-6.
1989: M Villella; M A Devoto; Fausto Avanzini; Claudio Alli; G Bettelli; F Colombo; M Di Tullio; Roberto Marchioli; G Mariotti; M Radice
Antihypertensive treatment of the elderly in general practice.
Journal of human hypertension 1989;3(4):221-6.
1989: Fausto Avanzini; Claudio Alli; G Bettelli; F Colombo; L Conforti; M A Devoto; M di Tullio; Roberto Marchioli; G Mariotti; F Pirone
Awareness, treatment, and control of hypertension in the elderly in a general practice experience. Study Group on Hypertension in the Elderly.
Clinical cardiology 1989;12(5):283-8.
1988: M Di Tullio; Claudio Alli; Fausto Avanzini; G Bettelli; F Colombo; M A Devoto; Roberto Marchioli; G Mariotti; M Radice; E Taioli
Prevalence of symptoms generally attributed to hypertension or its treatment: study on blood pressure in elderly outpatients (SPAA).
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1988;6(1):S87-90.